A new study found that male BRCA1/2 carriers have a higher risk for breast, pancreatic, and stomach cancer. Additionally, male BRCA2 carriers were found to have higher risks for prostate cancer. Read the full Journal of Clinical Oncology article to learn more!
https://ascopubs.org/doi/full/10.1200/JCO.21.02112
Reference: Li et al. J Clin Oncol. 2022 Jan 25;JCO2102112. PMID: 35077220.